2020 Q4 Form 10-Q Financial Statement

#000143774920022815 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $37.70M $44.26M $4.264M
YoY Change 784.15% 445.7% 171.77%
Cost Of Revenue $4.300M $5.559M $130.0K
YoY Change 3207.69% 654.3% 26.21%
Gross Profit $33.40M $38.70M $4.134M
YoY Change 707.93% 424.85% 181.99%
Gross Profit Margin 88.59% 87.44% 96.95%
Selling, General & Admin $3.400M $3.566M $3.497M
YoY Change -2.77% 11.57% -8.65%
% of Gross Profit 10.18% 9.21% 84.59%
Research & Development $3.000M $2.074M $3.924M
YoY Change -23.55% -37.98% 31.99%
% of Gross Profit 8.98% 5.36% 94.92%
Depreciation & Amortization $130.0K $130.0K $130.0K
YoY Change 0.0% -0.19% 550.0%
% of Gross Profit 0.39% 0.34% 3.14%
Operating Expenses $6.600M $5.640M $7.421M
YoY Change -11.06% -24.3% 9.12%
Operating Profit $26.80M $32.90M -$3.470M
YoY Change -872.33% 4880.21% -37.38%
Interest Expense -$600.0K $0.00 -$3.600M
YoY Change -83.33% -100.0% -35.71%
% of Operating Profit -2.24% 0.0%
Other Income/Expense, Net $100.0K $24.93K $600.0K
YoY Change -83.33% -96.72% -99.24%
Pretax Income $26.30M $31.65M -$6.500M
YoY Change -504.62% -2116.41% -109.62%
Income Tax $6.100M $7.500M -$2.000M
% Of Pretax Income 23.19% 23.7%
Net Earnings $20.20M $24.19M -$4.503M
YoY Change -548.59% -2105.92% -108.59%
Net Earnings / Revenue 53.58% 54.65% -105.61%
Basic Earnings Per Share $0.31 -$0.06
Diluted Earnings Per Share $260.3K $0.31 -$0.06
COMMON SHARES
Basic Shares Outstanding 77.40M 78.08M 80.94M shares
Diluted Shares Outstanding 78.17M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $117.9M $78.70M $65.20M
YoY Change 80.83% 0.77% -35.25%
Cash & Equivalents $117.9M $78.66M $65.25M
Short-Term Investments
Other Short-Term Assets $2.100M $1.300M $100.9M
YoY Change -97.92% -90.3% 538.61%
Inventory $20.27M $10.75M $9.653M
Prepaid Expenses
Receivables $3.340M $40.40M $4.168M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $143.6M $131.1M $180.0M
YoY Change -20.24% 32.93% 48.44%
LONG-TERM ASSETS
Property, Plant & Equipment $2.104M $2.237M $2.618M
YoY Change -19.64% -18.66% 1428.72%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $676.9K $702.9K $856.8K
YoY Change -20.99% -18.55% -19.09%
Total Long-Term Assets $6.223M $10.32M $18.52M
YoY Change -66.4% -90.11% -77.45%
TOTAL ASSETS
Total Short-Term Assets $143.6M $131.1M $180.0M
Total Long-Term Assets $6.223M $10.32M $18.52M
Total Assets $149.8M $141.4M $198.6M
YoY Change -24.54% -30.34% -2.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.278M $1.118M $3.054M
YoY Change -58.15% -50.34% 80.87%
Accrued Expenses $8.286M $15.18M $8.637M
YoY Change -4.07% 59.08% -10.49%
Deferred Revenue $3.281M $6.638M $2.298M
YoY Change 42.75%
Short-Term Debt $0.00 $0.00 $80.04M
YoY Change -100.0%
Long-Term Debt Due $0.00 $0.00 $80.00M
YoY Change -100.0%
Total Short-Term Liabilities $10.48M $16.30M $91.74M
YoY Change -88.57% 38.19% 709.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $9.600M $12.20M $9.000M
YoY Change 6.67% 29.79% -33.82%
Total Long-Term Liabilities $9.600M $12.20M $9.000M
YoY Change 6.67% -86.18% -89.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.48M $16.30M $91.74M
Total Long-Term Liabilities $9.600M $12.20M $9.000M
Total Liabilities $20.04M $28.46M $100.8M
YoY Change -80.12% -71.58% 0.25%
SHAREHOLDERS EQUITY
Retained Earnings -$95.19M -$108.6M -$123.0M
YoY Change -22.63% -8.35% 6.25%
Common Stock $225.0M $221.6M $220.8M
YoY Change 1.89% 0.09% 0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $129.8M $113.0M $97.78M
YoY Change
Total Liabilities & Shareholders Equity $149.8M $141.4M $198.6M
YoY Change -24.54% -30.34% -2.4%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $20.20M $24.19M -$4.503M
YoY Change -548.59% -2105.92% -108.59%
Depreciation, Depletion And Amortization $130.0K $130.0K $130.0K
YoY Change 0.0% -0.19% 550.0%
Cash From Operating Activities $45.95M $31.34M -$14.26M
YoY Change -422.23% 7735.0% 297.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.720M -5.740M -980.0K
YoY Change 585.71% 4000.0% -58.3%
NET CHANGE
Cash From Operating Activities 45.95M 31.34M -14.26M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -6.720M -5.740M -980.0K
Net Change In Cash 39.23M 25.60M -15.24M
YoY Change -357.41% 10566.67% -121.07%
FREE CASH FLOW
Cash From Operating Activities $45.95M $31.34M -$14.26M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow $45.95M $31.34M -$14.26M
YoY Change -422.23% 7361.9% 305.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14151002 USD
CY2020Q3 us-gaap Goodwill
Goodwill
898334 USD
CY2019Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
702885 USD
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77399505
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77770284
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77770284
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81269868
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81269868
siga Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-700000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019 siga Lessee Operating Lease First Renewal Term
LesseeOperatingLeaseFirstRenewalTerm
P2Y
CY2019 siga Lessee Operating Lease Second Renewal Term
LesseeOperatingLeaseSecondRenewalTerm
P3Y
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78663526 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65249072 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
95737862 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40398708 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4167996 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10747532 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
9652855 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1290388 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5234000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
131100154 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
180041785 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2236668 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2618303 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6484111 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
856766 USD
CY2020Q3 us-gaap Assets
Assets
141422152 USD
CY2019Q4 us-gaap Assets
Assets
198566190 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1118307 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3054032 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15182437 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
737274 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10465078 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8636911 USD
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80044866 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16300744 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91735809 USD
CY2020Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
9026690 USD
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6116882 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
3134304 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
2929743 USD
CY2020Q3 us-gaap Liabilities
Liabilities
28461738 USD
CY2019Q4 us-gaap Liabilities
Liabilities
100782434 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
7777 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8127 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
221587384 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220808037 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108634747 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123032408 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
112960414 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97783756 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
141422152 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
198566190 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44261407 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8111324 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87229949 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22478019 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5559215 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1652641 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3566258 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3196370 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10613267 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9755165 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2073613 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3343521 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7933404 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9379125 USD
CY2020Q3 siga Patent Preparation Fees
PatentPreparationFees
164102 USD
CY2019Q3 siga Patent Preparation Fees
PatentPreparationFees
173580 USD
siga Patent Preparation Fees
PatentPreparationFees
520902 USD
siga Patent Preparation Fees
PatentPreparationFees
543806 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
11363188 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
7450745 USD
us-gaap Costs And Expenses
CostsAndExpenses
29532651 USD
us-gaap Costs And Expenses
CostsAndExpenses
21330737 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
32898219 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
660579 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
57697298 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1147282 USD
CY2020Q3 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
1274156 USD
CY2019Q3 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-981923 USD
siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
2909808 USD
siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-4774711 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4981461 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
-0 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
3971952 USD
us-gaap Interest Expense
InterestExpense
3016817 USD
us-gaap Interest Expense
InterestExpense
11871401 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24932 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
759881 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
469226 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2233588 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31648995 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1569569 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47258438 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3715820 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7461038 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-363742 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11077854 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-977278 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
24187957 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1205827 USD
us-gaap Net Income Loss
NetIncomeLoss
36180584 USD
us-gaap Net Income Loss
NetIncomeLoss
-2738542 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78080461
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81064927
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79880493
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80988813
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78168070
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82181858
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80051778
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82148333
us-gaap Net Income Loss
NetIncomeLoss
36180584 USD
us-gaap Net Income Loss
NetIncomeLoss
-2738542 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
397136 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
395540 USD
siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
2909808 USD
siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-4774711 USD
us-gaap Share Based Compensation
ShareBasedCompensation
963372 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1717380 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7666891 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1065675 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4981461 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
887132 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3363712 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36230712 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1258568 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1507995 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1022951 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25572850 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1494821 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2189076 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
474736 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-697325 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4339626 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47939 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3940003 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
15501 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
29092 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15501 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29092 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
184009 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
199810 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21783289 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
85913459 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-107880757 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-199810 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-82323408 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4168905 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160986934 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180396910 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78663526 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176228005 USD
siga Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
0 USD
siga Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
1172801 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
118500 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100900000 USD
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78663526 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65249072 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
95737862 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78663526 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160986934 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78095231 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100652809 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
11053200 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11452078 USD
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
87079574 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
68292023 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176228005 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180396910 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2628153 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1657374 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8693457 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6462005 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
959398 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10747532 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
9652855 USD
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2497175 USD
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2966139 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
71541 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6360117 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6344616 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4123449 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3726313 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2236668 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2618303 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
397136 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
395540 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6637967 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2298341 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3705395 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7093 USD
CY2020Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
517643 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
981923 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2909808 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9026690 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
441992 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
419709 USD
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
423205 USD
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
256402 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
373376 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
643570 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
352594 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
288707 USD
CY2020Q3 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
233090 USD
CY2019Q4 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
707685 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
977724 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15182437 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8636911 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6116882 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
24187957 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1205827 USD
us-gaap Net Income Loss
NetIncomeLoss
36180584 USD
us-gaap Net Income Loss
NetIncomeLoss
-2738542 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4774711 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80051778
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82148333
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
24187957 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-2187750 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
36180584 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-7513253 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78080461
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81064927
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79880493
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80988813
CY2020Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
87609
CY2019Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1116931
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
171285
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1159520
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78168070
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82181858
CY2020Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
31300000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
19000 USD
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
700000 USD
CY2020Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
31600000 USD
CY2019Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1600000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7500000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
47300000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-3700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000.0 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236 pure
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232 pure
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
94133018 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
24187957 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5567121 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
174263 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
380823 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
112960414 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97783756 USD
us-gaap Net Income Loss
NetIncomeLoss
36180584 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21783289 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
184009 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
963372 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
112960414 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
103454467 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1205827 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
143220 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
761096 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
102866516 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
102914687 USD
us-gaap Net Income Loss
NetIncomeLoss
-2738542 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
siga Stock Issued During Period Value Stock Settled Appreciation Rights Exercised
StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised
0 USD
siga Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1172801 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
199810 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1717380 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
102866516 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
900000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3700000
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5600000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21800000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
500000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
400000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
100000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
100000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
400000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
400000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M21D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0453 pure
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
98915 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
600362 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
368467 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
402078 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
404258 USD
CY2020Q3 siga Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
982880 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2856960 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
388143 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2468817 USD

Files In Submission

Name View Source Status
0001437749-20-022815-index-headers.html Edgar Link pending
0001437749-20-022815-index.html Edgar Link pending
0001437749-20-022815.txt Edgar Link pending
0001437749-20-022815-xbrl.zip Edgar Link pending
ex_200402.htm Edgar Link pending
ex_200403.htm Edgar Link pending
ex_200404.htm Edgar Link pending
ex_200405.htm Edgar Link pending
ex_207022.htm Edgar Link pending
ex_207023.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20200930.xsd Edgar Link pending
siga-20200930_cal.xml Edgar Link unprocessable
siga-20200930_def.xml Edgar Link unprocessable
siga-20200930_lab.xml Edgar Link unprocessable
siga-20200930_pre.xml Edgar Link unprocessable
siga20200930_10q.htm Edgar Link pending
siga20200930_10q_htm.xml Edgar Link completed